8-K Announcements
6Material company update
May 18, 2026·SEC
Material company update
May 11, 2026·SEC
Material company update
Apr 21, 2026·SEC
Envoy Medical, Inc.(COCH)Earnings, Financials & Key Ratios
COCH•NASDAQ
$0.68
Price updated Jun 27, 2026
AboutEnvoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.Show more
- Revenue$241K+7.1%
- EBITDA-$22M-15.1%
- Net Income-$24M-14.2%
- EPS (Diluted)-1.23+17.4%
- Gross Margin-262.66%-14.3%
- EBITDA Margin-9115.35%-7.5%
- Operating Margin-9240.66%-8.0%
- Net Margin-9857.26%-6.7%
COCH Price & Volume
Envoy Medical, Inc. (COCH) stock price & volume — 10-year historical chart
Loading chart...
Persistent Operating Deficits Threaten Commercial Viability
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent liquidity and dilution
"Envoy Medical faces a precarious financial outlook characterized by a structural inability to achieve positive gross margins, which stood at -7.0% in 2026Q1. The company's reliance on external capital to offset massive R&D expenditures—totaling $3.6 million in the most recent quarter—suggests a high risk of continued shareholder dilution. Investors should monitor the company's ability to scale the Esteem system, as the current revenue of $39,000 remains insufficient to cover basic operational costs."
Verdict Logic
the company's inability to generate positive operating cash flow, evidenced by a $6.1 million outflow in 2026Q1, presents an imminent liquidity risk that outweighs potential long-term clinical upside.
COCH Growth Metrics
Envoy Medical, Inc. (COCH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years0.56%
TTM10.38%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-18.37%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM20.72%
Return on Capital
10 Years-2150.23%
5 Years-2150.23%
3 Years-2944.51%
Last Year-4471.89%
COCH Recent Earnings
Envoy Medical, Inc. (COCH) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (20%)●Beat Revenue 2/12 qtrs (25%)
Q2 2026Latest
May 11, 2026Metric
Actual
Est
EPS
$0.11+21.4%
$0.14
Rev
$39,000-61.0%
$100,000
Q2 2026
Mar 23, 2026Metric
Actual
Est
EPS
$0.26-8.3%
$0.24
Rev
$100,000+233.3%
$30,000
Q4 2025
Nov 10, 2025Metric
Actual
Est
EPS
$0.35-29.6%
$0.27
Rev
$42,000-30.0%
$60,000
Q3 2025
Jul 31, 2025Metric
Actual
Est
EPS
$0.32-10.3%
$0.29
Rev
$78,000+17.7%
$66,250
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 11, 2026 | $0.11vs $0.14+21.4% | $39,000vs $100,000-61.0% |
| Q2 2026 | Mar 23, 2026 | $0.26vs $0.24-8.3% | $100,000vs $30,000+233.3% |
| Q4 2025 | Nov 10, 2025 | $0.35vs $0.27-29.6% | $42,000vs $60,000-30.0% |
| Q3 2025 | Jul 31, 2025 | $0.32vs $0.29-10.3% | $78,000vs $66,250+17.7% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Envoy Medical, Inc. (COCH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.68 | $14.11M | -0.55 | 7.11% | -9857.26% | — | 13.68% | |
| $109.80 | $7.15B | 32.20 | 0.5% | 18.05% | 24.33% | — | |
| $80.98 | $103.97B | 21.71 | 8.43% | 13.2% | 9.78% | — | |
| $93.82 | $163.42B | 25.22 | 5.67% | 13.91% | 12.09% | — | |
| $44.23 | $65.74B | 22.80 | 19.87% | 17.23% | 14.67% | — | |
| $350.85 | $25.29B | 51.60 | 6.26% | 16.85% | 17.87% | — |
Compare COCH vs Peers
Envoy Medical, Inc. (COCH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
COCH SEC Filings & Documents
Envoy Medical, Inc. (COCH) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when COCH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
COCH Frequently Asked Questions
Envoy Medical, Inc. (COCH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Envoy Medical, Inc.'s revenue?
Envoy Medical, Inc. (COCH) reported $0.2M in revenue for fiscal year 2025. This represents a 25% decrease from $0.3M in 2021.
How fast is Envoy Medical, Inc. growing?
Envoy Medical, Inc. (COCH) grew revenue by 7.1% over the past year. This is steady growth.
Is COCH profitable?
Envoy Medical, Inc. (COCH) reported a net loss of $23.1M for fiscal year 2025.
Dividend & Returns
Does COCH pay dividends?
Yes, Envoy Medical, Inc. (COCH) pays a dividend with a yield of 13.68%. This makes it attractive for income-focused investors.
What is Envoy Medical, Inc.'s free cash flow?
Envoy Medical, Inc. (COCH) had negative free cash flow of $20.7M in fiscal year 2025, likely due to heavy capital investments.